Morris Arlene

DirectorCogent Biosciences, Inc. (COGT) · full profile →Form 4 · filed Aug 31, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.7M
Net Open-Market Flow
-$1.7M
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 27, 2026Option exercise(M)42K$5.64$236K42K
Aug 27, 2026Option exercise(M)4K$2.52$9K46K
Aug 27, 2026Sell(S)42K$37.09$1.6M3K
Aug 27, 2026Sell(S)3K$37.54$119K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 27, 2026Option exercise(M)42K$03K
Aug 27, 2026Option exercise(M)4K$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-377001) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.